Molecular Biology of the Dopamine Receptor Subtypes

O. Civelli
F. Hoffmann–La Roche Ltd.,
Basel, Switzerland.


1. Albert PR, Neve KA, Bunzow JR, Civelli O. Coupling of a cloned rat dopamine D2 receptor to inhibition of adenylyl cyclase and prolactin secretion. J Biol Chem 1990;265:2098–2104.

2. Andersen PH, Gingrich JA, Bates MD, et al. Dopamine receptor subtypes: beyond the D1/D2 classification. Trends Pharmacol Sci 1990;11:231–236.

3. Bertorello AM, Hopfield JF, Aperia A, Greengard P. Inhibition by dopamine of (Na+ + K+) ATPase activity in neostriatal neurons through D1 and D2 dopamine receptor synergism. Nature 1990;347:386–388.

4. Birkmayer W, Hornykiewicz O. Der L-Dioxyphenylalanin (=L-DOPA)-Effekt beim Parkinson-Syndrom des Menschen: Zur Pathogenese and Behandlung der Parkinson-Akinese. Arch Psychiatr Nervenkr 1962;203:560–574.

5. Bjorklund A, Lindvall O. Dopamine-containing systems in the CNS. In: Bjorklund A, Hokfelt T, eds. Classical transmitters in the CNS. Handbook of chemical neuroanatomy. Amsterdam: Elsevier, 1964;55–122.

6. Bunzow JR, Van Tol HHM, Grandy DK, et al. Cloning and expression of a rat D2 dopamine receptor cDNA. Nature 1988;336:783–787.

7. Carlsson A. The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1988;1:179–186.

8. Carlsson A, Lindqvist M. Effect of chlorpromazine and haloperidol on the formation of 3-methoxytyramine in mouse brain. Acta Pharmacol 1963;20:140–144.

9. Chen JF, Qin ZH, Szele F, Bai G, Weiss B. Neuronal localization and modulation of the D2 dopamine receptor mRNA in brain of normal mice and mice lesioned with 6-hydroxydopamine. Neuropharmacology 1991;30:927–941.

10. Chio CL, Hess GF, Graham RS, Hugg RM. A second molecular form of D2 dopamine receptor in rat and bovine caudate nucleus. Nature 1990;343:266–269.

11. Civelli O, Bunzow JR, Grandy DK. Molecular diversity of the dopamine receptors. Annu Rev Pharmacol Toxicol 1992;32:281–307.

12. Creese I, Burt DR, Snyder SH. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 1976;192:481–483.

13. Creese I, Fraser CM. Dopamine receptors. New York: Alan R Liss, 1987.

14. Dal Toso R, Sommer B, Ewert M, et al. The dopamine D2 receptor: two molecular forms generated by alternative splicing. EMBO J 1989;8:4025–4034.

15. Dearry A, Gingrich JA, Falardeau P, Fremeau RT, Bates MD, Caron MG. Molecular cloning and expression of the gene for a human D1 dopamine receptor. Nature 1990;347:72–76.

16. Dixon RAF, Sigal IS, Strader CD. Structure-function analysis of the b-adrenergic receptor. Cold Spring Harbor Symp 1988;53:487–498.

17. Dohlman HG, Caron MG, Lefkowitz RJ. A family of receptors coupled to guanine nucleotide regulatory proteins. Biochemistry 1987;26:2657–2664.

18. Ehringer H, Hornykiewicz O. Verteilung von Noradrenalin and Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des Extrapyramidalen Systems. Klin Wochenschr 1960;38:1236–1239.

19. Felder RA, Felder CA, Eisner GM, Jose PA. The dopamine receptor in adult and maturing kidney. Am J Physiol 1989;257:F315–F327.

20. Fremeau RT Jr, Duncan GE, Fornaretto MG, et al. Localization of D1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission. Proc Natl Acad Sci USA 1991;88:3772–3776.

21. Gerfen CR, Engber TM, Mahan LC, et al. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 1990;250:1429–1430.

22. Giros B, Martres MP, Pilon C, Sokoloff P, Schwartz JC. Shorter variants of the D3 dopamine receptor produced through various patterns of alternative splicing. Biochem Biophys Res Commun 1991;176:1584–1592.

23. Giros B, Sokoloff P, Martres MP, Rious JF, Emorine LJ, Schwartz JC. Alternative splicing directs the expression of two D2 dopamine receptor isoforms. Nature 1989;342:923–926.

24. Grandy DK, Allen LJ, Zhang Y, Zhou QY, Magenis RE, Civelli O. Chromosomal localization of the three human D5 dopamine receptor genes. Genomics 1992;13:968–973.

25. Grandy DK, Marchionni MA, Makam H, et al. Cloning of the cDNA and gene for a human D2 dopamine receptor. Proc Natl Acad Sci USA 1989;86:9762–9766.

26. Grandy DK, Zhang Y, Bouvier C, et al. Multiple D5 dopamine receptor genes: a functional receptor and two pseudogenes. Proc Natl Acad Sci USA 1991;88:9175–9179.

27. Hall ZA. Three of a kind: the b-adrenergic receptor, the muscarinic acetylcholine receptor, and rhodopsin. Trends Neuro Sci 1987; 10:99–100.

28. Hayes G, Biden TJ, Selbie LA. Structural subtypes of the dopamine D2 receptor are functionally distinct: expression of the cloned D2A and D2B subtypes in a heterologous cell line. Mol Endocrinol 1992;6:920–926.

29. Hornykiewicz O. Dopamine and brain function. Pharmacol Res 1966;18:925–964.

30. Kebabian JW, Calne DB. Multiple receptors for dopamine. Nature 1979;277:93–96.

31. Leff SE, Creese I. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum: evidence the [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor. Mol Pharmacol 1985;27:184–192.

32. Lefkowitz RJ, Kobilka BK, Benovic JL, et al. Molecular biology of adrenergic receptors. Cold Spring Harbor Symp 1988;53:507–514.

33. Levesque D, Diaz J, Pilon C, et al. Identification, characterization and localization of the dopamine D3 receptor in the brain using 7-[3H]hydroxy-NN-di-n-propyl-2-amino tetralin. Proc Natl Acad Sci USA 1992;89:8155–8159.

34. Mansour A, Meador-Woodruff J, Bunzow J, Civelli O, Akil H, Watson S. Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat brain and pituitary: an in situ hybridization-receptor audoradiographic analysis. J Neurosci 1990;10:2587–2600.

35. Mansour A, Meador-Woodruff JH, Camp DM, et al. The effects of nigrostriatal 6-hydroxydopamine lesions on dopamine D2 receptor mRNA and opioid systems. Alan R. Liss, Inc., 1989.

36. Meador-Woodruff JH, Mansour A, Bunzow JR, Van Tol HHM, Watson S, Civelli O. Distribution of D2 dopamine receptor mRNA in rat brain. Proc Natl Acad Sci USA 1989;86:7625–7628.

37. Meador-Woodruff JH, Mansour A, Grandy DK, Damask SP, Civelli O, Watson SJ. Distribution of D5 dopamine receptor mRNA in rat brain. Neurosci Lett 1992;145:209–212.

38. Meador-Woodruff JH, Mansour A, Healty DJ, et al. Comparison of the distributions of D1 and D2 dopamine receptor mRNAs in rat brain. Neuropsychopharmacology 1991;5:231–242.

39. Mengod G, Martinez-Mir MI, Vilaro MT, Palacios JM. Localization of the mRNA for the dopamine D2 receptor in the rat brain by in situ hybridization histochemistry. Proc Natl Acad Sci USA 1989;86:8560–8564.

40. Miller JC, Wang Y, Filer D. Identification by sequence analysis of a second rat brain cDNA encoding the dopamine D2 receptor. Biochem Biophys Res Commun 1990;166:109–112.

41. Monsma FJ Jr, Mahan LC, McVittie LD, Gerfen CR, Sibley DR. Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation. Proc Natl Acad Sci USA 1990;87:6723–6727.

42. Monsma FJ Jr, McVittie LD, Gerfen CR, Mahan LC, Sibley DR. Multiple D2 dopamine receptors produced by alternative RNA splicing. Nature 1989;342:926–929.

43. Montmayeur JP, Borrelli E. Transcription mediated by a cAMP-responsive promoter element is reduced upon activation of dopamine D2 receptors. Proc Natl Acad Sci USA 1991;88:3135–3139.

44. Najlerahim A, Barton AJL, Harrison PJ, Heffernan J, Pearson RCA. Messenger RNA encoding the D2 dopaminergic receptor detected by in situ hybridization histochemistry in rat brain. FEBS Lett 1989;255:335–339.

45. Neve KA, Henningsten RA, Bunzow JR, Civelli O. Functional characterization of a rat dopamine D2 receptor cDNA expressed in mammalian cell lines. Mol Pharmacol 1989;36(3):446–451.

46. O'Dowd BF, Hnatowich M, Caron MG, Lefkowitz RJ, Bouvier M. Palmitoylation of the human b2-adrenergic receptor. J Biol Chem 1989;264:7564–7569.

47. O'Malley KL, Harmon S, Tang L, Todd RD. The rat dopamine D4 receptor: sequence, gene, structure, and demonstration of expression in the cardiovascular system. New Biol 1992;4:137–146.

48. O'Malley KL, Mack KJ, Gandelman KY, Todd RD. Organization and expression of the rat D2A receptor gene: identification of alternative transcripts and a variant donor splice site. Biochemistry 1990;29:1367–1371.

49. Poirier LJ, Sourkes TL. Influence of the substantia nigra on the catecholamine content of the striatum. Brain 1965;88:181–192.

50. Seeman P, Lee T, Chan-Wong M, Wong K. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 1976;261:717–719.

51. Seeman P, Niznik HB, Guan H-C, Booth G, Ulpian C. Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain. Proc Natl Acad Sci USA 1989; 86:10156–10160.

52. Selbie LA, Hayes G, Shine J. The major dopamine D2 receptors: molecular analysis of the human D2A subtype. DNA 1989;8:683–689.

53. Snyder LA, Roberts JL, Sealfon SC. Alternative transcripts of the rat and human dopamine D3 receptor. Biochem Biophys Res Commun 1991;180:1031–1035.

54. Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 1990;347:146–151.

55. Sunahara RK, Guan HC, O'Dowd BF, et al. Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Nature 1991;350:614–619.

56. Sunahara RK, Niznik HB, Weiner DM, et al. Human dopamine D1 receptor encoded by an intronless gene on chromosome 5. Nature 1990;347:80–83.

57. Tiberi M, Jarvie KR, Silvia C, et al. Cloning, molecular characterization and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1 receptor. Proc Natl Acad Sci USA 1991;88:7491–7495.

58. Van Tol HHM, Bunzow JR, Guan HC, et al. Cloning of a human dopamine D4 receptor gene with high affinity for the antipsychotic clozapine. Nature 1991;350:610–614.

59. Van Tol HMM, Wu CM, Guan HC, et al. Multiple dopamine D4 receptor variants in the human population. Nature 1992;358:149–152.

60. Waddington JL. Functional interactions between D1 and D2 dopamine receptor systems: their role in the regulation of psychomoter behavior, putative mechanisms, and clinical relevance. J Psycopharmacol 1989;3:54–63.

61. Walters JR, Bergstrom DA, Carlson JH, Chase TN, Braun AR. D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects. Science 1987;269:719–722.

62. Weiner DM, Brann MR. The distribution of a dopamine D2 receptor mRNA in rat brain. FEBS Lett 1989;253:207–213.

63. Zhou QY, Grandy D, Thambi L, et al. Cloning and expression of human and rat D1 dopamine receptors. Nature 1990;347:76–80.

Back to Chapter

published 2000